CL2019001938A1 - Composiciones probióticas y usos de las mismas. - Google Patents
Composiciones probióticas y usos de las mismas.Info
- Publication number
- CL2019001938A1 CL2019001938A1 CL2019001938A CL2019001938A CL2019001938A1 CL 2019001938 A1 CL2019001938 A1 CL 2019001938A1 CL 2019001938 A CL2019001938 A CL 2019001938A CL 2019001938 A CL2019001938 A CL 2019001938A CL 2019001938 A1 CL2019001938 A1 CL 2019001938A1
- Authority
- CL
- Chile
- Prior art keywords
- lactobacillus
- prevention
- probiotic compositions
- treatment
- combination
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000006041 probiotic Substances 0.000 title abstract 2
- 230000000529 probiotic effect Effects 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 208000015943 Coeliac disease Diseases 0.000 abstract 3
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 2
- 240000006024 Lactobacillus plantarum Species 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1700542.2A GB201700542D0 (en) | 2017-01-12 | 2017-01-12 | Probiotic compositions and uses thereof |
| GBGB1709731.2A GB201709731D0 (en) | 2017-06-19 | 2017-06-19 | Probiotic compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2019001938A1 true CL2019001938A1 (es) | 2019-09-27 |
Family
ID=61386800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019001938A CL2019001938A1 (es) | 2017-01-12 | 2019-07-11 | Composiciones probióticas y usos de las mismas. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11166993B2 (enExample) |
| EP (1) | EP3568144B1 (enExample) |
| JP (1) | JP7089523B2 (enExample) |
| KR (1) | KR102500496B1 (enExample) |
| CN (1) | CN110177561B (enExample) |
| AU (1) | AU2018207946B2 (enExample) |
| BR (1) | BR112019014418A2 (enExample) |
| CA (1) | CA3049624A1 (enExample) |
| CL (1) | CL2019001938A1 (enExample) |
| MX (1) | MX2019008292A (enExample) |
| MY (1) | MY195253A (enExample) |
| PH (1) | PH12019501629A1 (enExample) |
| RU (1) | RU2763311C2 (enExample) |
| WO (1) | WO2018130667A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020013439A (es) * | 2018-06-18 | 2021-05-12 | Probi Ab | Composiciones probioticas y usos de las mismas. |
| IT201900014550A1 (it) * | 2019-08-09 | 2021-02-09 | Abiogen Pharma Spa | Uso di colecalciferolo come agente attivo nel trattamento della celiachia |
| CN116869141A (zh) * | 2022-05-05 | 2023-10-13 | 内蒙古一康健康发展有限责任公司 | 一种具有保健功能的益生菌复合物及其制备方法 |
| KR102845919B1 (ko) * | 2023-02-28 | 2025-08-14 | 주식회사 피엘비앤비 | 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물 |
| CN119279210A (zh) * | 2024-12-16 | 2025-01-10 | 山东健源生物科技有限公司 | 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| ZA200802934B (en) * | 2005-10-06 | 2009-09-30 | Probi Ab | Use of lactobacillus for treatment of virus infections |
| EP1951273B1 (en) | 2005-10-06 | 2014-02-12 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| PL1996696T3 (pl) | 2006-03-17 | 2017-08-31 | Probi Aktiebolag | Termostabilne szczepy Lactobacillus |
| WO2007108763A1 (en) * | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
| PT2367561E (pt) | 2008-11-30 | 2015-10-23 | Immusant Inc | Composições e métodos para o tratamento da doença celíaca |
| EP2581461B1 (en) * | 2011-10-14 | 2014-09-24 | GenMont Biotech Incorporation | Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
| RU2654705C2 (ru) * | 2012-06-18 | 2018-05-22 | Г.Дж. Хайнц Компани Брэндс ЛЛК | Глютенозависимые расстройства |
| AU2014250113B2 (en) * | 2013-04-03 | 2017-03-30 | Probi Ab | Probiotic strains for use in treatment or prevention of osteoporosis |
| WO2016083450A2 (en) * | 2014-11-25 | 2016-06-02 | Stichting Top Institute Food And Nutrition | New probiotic and new biomarker |
-
2018
- 2018-01-12 WO PCT/EP2018/050789 patent/WO2018130667A1/en not_active Ceased
- 2018-01-12 EP EP18707627.8A patent/EP3568144B1/en active Active
- 2018-01-12 US US16/477,259 patent/US11166993B2/en active Active
- 2018-01-12 CN CN201880006818.0A patent/CN110177561B/zh active Active
- 2018-01-12 RU RU2019121145A patent/RU2763311C2/ru active
- 2018-01-12 AU AU2018207946A patent/AU2018207946B2/en active Active
- 2018-01-12 MY MYPI2019003890A patent/MY195253A/en unknown
- 2018-01-12 KR KR1020197022803A patent/KR102500496B1/ko active Active
- 2018-01-12 BR BR112019014418A patent/BR112019014418A2/pt unknown
- 2018-01-12 JP JP2019538207A patent/JP7089523B2/ja active Active
- 2018-01-12 MX MX2019008292A patent/MX2019008292A/es unknown
- 2018-01-12 CA CA3049624A patent/CA3049624A1/en active Pending
-
2019
- 2019-07-11 CL CL2019001938A patent/CL2019001938A1/es unknown
- 2019-07-12 PH PH12019501629A patent/PH12019501629A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3568144C0 (en) | 2024-05-08 |
| EP3568144A1 (en) | 2019-11-20 |
| MY195253A (en) | 2023-01-11 |
| US11166993B2 (en) | 2021-11-09 |
| CN110177561B (zh) | 2023-09-12 |
| CA3049624A1 (en) | 2018-07-19 |
| AU2018207946A1 (en) | 2019-07-25 |
| PH12019501629A1 (en) | 2020-06-01 |
| KR102500496B1 (ko) | 2023-02-16 |
| RU2763311C2 (ru) | 2021-12-28 |
| EP3568144B1 (en) | 2024-05-08 |
| US20190358275A1 (en) | 2019-11-28 |
| AU2018207946B2 (en) | 2024-07-18 |
| RU2019121145A (ru) | 2021-02-12 |
| MX2019008292A (es) | 2019-09-16 |
| CN110177561A (zh) | 2019-08-27 |
| RU2019121145A3 (enExample) | 2021-04-26 |
| BR112019014418A2 (pt) | 2020-04-14 |
| JP7089523B2 (ja) | 2022-06-22 |
| WO2018130667A1 (en) | 2018-07-19 |
| JP2020513780A (ja) | 2020-05-21 |
| KR20190104568A (ko) | 2019-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019001938A1 (es) | Composiciones probióticas y usos de las mismas. | |
| BR112015025256A8 (pt) | Cepas probióticas para uso no tratamento ou prevenção da osteoporose | |
| EA202091389A1 (ru) | Композиция на основе пробиотиков и её применение | |
| AR110684A1 (es) | Composiciones que comprenden cepas bacterianas y método de tratamiento | |
| MX395076B (es) | COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS. | |
| CL2018001936A1 (es) | Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación. | |
| BR112018003123A2 (pt) | composição, enema, cepa isolada, método para tratamento e/ou prevenção de uma condição gastrointestinal, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada | |
| BR112021025676A2 (pt) | Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella | |
| AR107921A1 (es) | Uso de probióticos en el tratamiento y/o la prevención de la enfermedad de la psoriasis | |
| MX2017016283A (es) | Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos. | |
| BR112017023636A2 (pt) | suplemento dietético | |
| MX2020013439A (es) | Composiciones probioticas y usos de las mismas. | |
| MX392754B (es) | Seleccion de cepas bacterianas utiles en el tratamiento de la alergia. | |
| BR112019001919A2 (pt) | composição de tratamento de superfícies rígidas, método para fornecer o brilho da superfície e utilização da composição | |
| MX2024006254A (es) | Uso de postbioticos en el tratamiento y/o prevencion de los trastornos de ansiedad. | |
| BR112021020617A2 (pt) | Composições probióticas e usos das mesmas | |
| CO2017007338A2 (es) | Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina | |
| CO2018001271A2 (es) | Composición microbiana de microorganismos probióticos | |
| CO2020009424A2 (es) | Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas | |
| BR112018071493A2 (pt) | usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce | |
| MX2018012312A (es) | Lactobacillus rhamnosus para su uso en la preparacion de productos fermentados. | |
| CO2024015660A2 (es) | Composiciones probióticas para el tratamiento de la alopecia | |
| MX2016013880A (es) | Una composicion sinergica que comprende una mezcla de bacterias del género lactobacillus y propionobacterium particularmente útil para reducir o eliminar la contaminacion de patogenos en harina de soja y sus derivados; métodos y usos. | |
| PL416198A1 (pl) | Kompozycja farmaceutyczna zawierająca połączenie kwasu hialuronowego i roślinnych fitoestrogenów do aplikacji waginalnej | |
| AR112592A1 (es) | Composiciones que comprenden cepas bacterianas, métodos |